Mechanisms causing loss of lean body mass in kidney disease

American Journal of Clinical Nutrition

Volumn 67, Issue 3, 1998, Pages 359-366

  Mitch, William E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic renal failure; Glucocorticoids; Humans; Kidney disease; Lean body mass; Proteasome; Proteolysis; Robert H Herman Memorial Award in Clinical Nutrition; Ubiquitin; Uremia

Indexed keywords

2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); BRANCHED CHAIN AMINO ACID; GLUCOCORTICOID; INSULIN; PROTEASOME; UBIQUITIN; CYSTEINE PROTEINASE; MULTIENZYME COMPLEX; MUSCLE PROTEIN;

ANOREXIA; CHRONIC KIDNEY FAILURE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; LEAN BODY WEIGHT; MALNUTRITION; METABOLIC ACIDOSIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN RESTRICTION; REVIEW; UREMIA; CACHEXIA; CALORIC INTAKE; HYDROLYSIS; METABOLISM; SIGNAL TRANSDUCTION;

CACHEXIA; CYSTEINE ENDOPEPTIDASES; ENERGY INTAKE; HUMANS; HYDROLYSIS; KIDNEY DISEASES; MULTIENZYME COMPLEXES; MUSCLE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; UBIQUITINS;

EID: 0031911147     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/67.3.359     Document Type: Review

References (72)

1. Coles GA. Body composition in chronic renal failure. Q J Med 1972;41:25-47.
2. Bergstrom J. Why are dialysis patients malnourished? Am J Kidney Dis 1995;26:229-41.
3. Druml W. Nutritional support in acute renal failure. In: Mitch WE, Klahr S, eds. Nutrition and the kidney. 2nd ed. Boston: Little, Brown and Company, 1993:314-45.
4. Maroni BJ, Mitch WE. Role of nutrition in prevention of the progression of renal disease. Annu Rev Nutr 1997;17:435-55.
5. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of the death rate differences among facilities. Am J Kidney Dis 1990;15:458-82.
6. Giordano C. Use of exogenous and endogenous urea for protein synthesis in normal and uremic subjects. J Lab Clin Med 1963;62:231-46.
7. Hakim RM, Lazarus JM. Initiation of dialysis. J Am Soc Nephrol 1995;6:1319-28.
8. FAO/WHO/UNU. Energy and protein requirements. World Health Organ Tech Rep Ser 1985;724.
9. Maroni BJ. Requirements for protein, calories, and fat in the predialysis patient. In: Mitch WE, Klahr S, eds. Nutrition and the kidney. 2nd ed. Boston: Little, Brown and Co, 1993:185-212.
10. Mitch WE, Abras E, Walser M. Long-term effects of a new ketoacid-amino acid supplement in patients with chronic renal failure. Kidney Int 1982;22:48-53.
11. Tom K, Young VR, Chapman T, Masud T, Akpele L, Maroni BJ. Long-term adaptive responses to dietary protein restriction in chronic renal failure. Am J Physiol 1995;268:E668-77.
12. Avram MM, Goldwasser P, Erroa M, Fein PA. Predictors of survival in continuous ambulatory peritoneal dialysis. The importance of prealbumin and other nutritional and metabolic markers. Am J Kidney Dis 1994;23:91-8.
13. Kaysen GA, Rathore V, Shearer GC, Depner TA. Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 1995;48:510-6.
14. Kopple JD, Monteon FJ, Shaib JK. Effect of energy intake on nitrogen metabolism in nondialyzed patients with chronic renal failure. Kidney Int 1986;29:734-42.
15. Slomowitz LA, Monteon FJ, Grosvenor M, Laidlaw SA, Kopple JD. Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int 1989;35:704-11.
16. Kopple JD, Levey AS, Greene T, et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease (MDRD) Study. Kidney Int 1997;52:778-91.
17. Walser M. Does prolonged protein restriction preceding dialysis lead to protein malnutrition at the onset of dialysis? Kidney Int 1993;44:1139-44.
18. Maroni BJ, Burkart J, Burrowes J, et al. Baseline nutritional characteristics of the HEMO Study participants: interim report. J Am Soc Nephrol 1996;7:1456 (abstr).
19. Coresh J, Walser M, Hill S. Survival on dialysis among chronic renal failure patients treated with a supplemented low-protein diet before dialysis. J Am Soc Nephrol 1995;6:1379-85.
20. Motil KJ, Matthews DE, Bier DM, Burke JF, Munro HN, Young VR. Whole-body leucine and lysine metabolism: response to dietary protein intake in young men. Am J Physiol 1981;240:E712-21.
21. Goodship THJ, Mitch WE, Hoerr RA, Wagner DA, Steinman TI, Young VR. Adaptation to low-protein diets in renal failure: leucine turnover and nitrogen balance. J Am Soc Nephrol 1990;1:66-75.
22. Maroni BJ, Staffeld C, Young VR, Manatunga A, Tom K. Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet. J Clin Invest 1997;99:2479-87.
23. Hara Y, May RC, Kelly RA, Mitch WE. Acidosis, not azotemia, stimulates branched-chain amino acid catabolism in uremic rats. Kidney Int 1987;32:808-14.
24. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitin-proteasome pathway. J Clin Invest 1996;97:1447-53.
25. Reaich D, Channon SM, Scrimgeour CM, Goodship THJ. Ammonium chloride-induced acidosis increases protein breakdown and amino acid oxidation in humans. Am J Physiol 1992;263:E735-9.
26. Reaich D, Channon SM, Scrimgeour CM, Daley SE, Wilkinson R, Goodship THJ. Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 1993;265:E230-5.
27. Williams B, Hattersley J, Layward E, Walls J. Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. Kidney Int 1991;40:779-86.
28. Ballmer PE, McNurlan MA, Hulter HN, Anderson SE, Garlick PJ, Krapf R. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 1995;95:39-45.
29. Mitch WE, Goldberg AL. Mechanisms of muscle wasting: the role of the ubiquitin-proteasome system. N Engl J Med 1996;335:1897-905.
30. Harper AE, Miller RH, Block KP. Branched-chain amino acid metabolism. Annu Rev Nutr 1984;4:409-54.
31. Mitch WE, Clark AS. Specificity of the effect of leucine and its metabolites on protein degradation in skeletal muscle. Biochem J 1984;222:579-86.
32. Mitch WE, Walser M. Nutritional therapy of the uremic patient. In: Brenner BM, Rector FC, eds. The kidney. 5th ed. New York: WB Saunders, 1996:2382-423.
33. May RC, Hara Y, Kelly RA, Block KP, Buse MG, Mitch WE. Branched-chain amino acid metabolism in rat muscle: abnormal regulation in acidosis. Am J Physiol 1987;252:E712-8.
34. England BK, Greiber S, Mitch WE, et al. Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia. Am J Physiol 1995;268:C1395-400.
35. May RC, Bailey JL, Mitch WE, Masud T, England BK. Glucocorticoids and acidosis stimulate protein and amino acid catabolism in vivo. Kidney Int 1996;49:679-83.
36. Wang X, Jurkovitz C, Price SR. Regulation of branched-chain ketoacid dehydrogenase flux by extracellular pH and glucocorticoids. Am J Physiol 1997;272:C2031-6.
37. Mochizuki T. The effect of metabolic acidosis on amino and keto acid metabolism in chronic renal failure. Jpn J Nephrol 1991;33:213-24.
38. Lofberg E, Wernerman J, Anderstam B, Bergstrom J. Correction of metabolic acidosis in dialysis patients increases branched-chain and total essential amino acids. Clin Nephrol 1997;48:230-7.
39. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 1994;78:773-85.
40. Scheffner M, Huilegtse JM, Viestra RD, Howley PM. The HPV-16E6 and E6AP complex functions as a ubiquitin protein ligase in the ubiquitination of p53. Cell 1993;75:495-505.
41. Jensen TJ, Loo MA, Pind S, Williams DB, Goldberg AL, Riordan JR. Multiple proteolytic systems, including the proteasome contribute CFTR processing. Cell 1995;83:129-35.
42. Rock KL, Gramm C, Rothstein L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class 1 molecules. Cell 1994;78:761-71.
43. Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996;65:801-47.
44. Hershko A, Cieehanover A. The ubiquitin system for protein degradation. Annu Rev Biochem 1992;61:761-807.
45. Lowe J, Stock D, Jap B, Zwickl P, Baumeister W, Huber R. Crystal structure of the 20S proteasome from the Archaeon T. acidophilum at 3.4 A resolution. Science 1993;268:533-9.
46. Seemuller E, Lupas A, Sock D, Lowe J, Huber R, Baumeister W. Proteasome from Thermoplasma acidophilum: a threonine protease. Science 1995;268:579-82.
47. Vinitsky A, Cardozo C, Sepp-Lorenzino L, Michaud C, Orlowski M. Inhibition of the proteolytic activity of the multicatalytic proteinase complex (Proteasome) by substrate-related peptidyl aldehydes. J Biol Chem 1994;269:29860-6.
48. Wing SS, Goldberg AL. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol 1993;264:E668-76.
49. Mitch WE, Medina R,Greiber S, et al. Metabolic acidosis stimulates muscle protein degradation by activating the ATP-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 1994;93:2127-33.
50. Price SR, Bailey JL, Wang X, et al. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome pathway by a mechanism including gene transcription. J Clin Invest 1996;98:1703-8.
51. Reaich D, Grewal M, Price SR, et al. Catabolism in acute renal failure (ARF): evidence for stimulation of the ubiquitin-proteasome system and activation of branched-chain a-ketoacid dehydrogenase (BCKAD). J Am Soc Nephrol 1994;5:953 (abstr).
52. Wing SS, Haas AL, Goldberg AL. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. Biochem J 1995;307:639-45.
53. May RC, Kelly RA, Mitch WE. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 1986;77:614-21.
54. Price SR, England BK, Bailey JL, Van Vreede K, Mitch WE. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am J Physiol 1994;267:C955-60.
55. Isozaki Y, Mitch WE, England BK, Price SR. Interaction between glucocorticoids and acidification results in stimulation of proteolysis and mRNAs of proteins encoding the ubiquitin-proteasome pathway in BC3H-1 myocytes. Proc Natl Acad Sci U S A 1996;93:1967-71.
56. Breuille D, Farge MCF, Arnal M, Attaix D, Obled C. Pentoxifylline decreases body weight loss and muscle protein wasting characteristics of sepsis. Am J Physiol 1993;265:E660-6.
57. Costelli P, Carbo N, Tessitore L, et al. Tumor necrosis factor-a mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 1993;92:2783-9.
58. Goodman MN. lnterleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med 1994;205:182-5.
59. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B. Influence of uremia and hemodialysis on circulating imerleukin-1 and tumor necrosis factor α. Kidney Int 1990;37:116-27.
60. May RC, Kelly RA, Mitch WE. Mechanisms for defects in muscle protein metabolism in rats with chronic uremia: the influence of metabolic acidosis. J Clin Invest 1987;79:1099-103.
61. + antiporter. J Am Soc Nephrol 1995;5:1689-96.
62. Bailey JL, England BK, Long RC, Weisman J, Mitch WE. Experimental acidemia and muscle cell pH in chronic acidosis and renal failure. Am J Physiol 1995;269:C706-12.
63. Papadoyannakis NJ, Stefanidis CJ, McGeown M. The effect of the correction of metabolic acidosis on nitrogen and protein balance of patients with chronic renal failure. Am J Clin Nutr 1984;40:623-7.
64. Garibotto G, Russo R, Sofia A, et al. Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int 1994;45:1432-9.
65. Graham KA, Reaich D, Channon SM, Downie S, Goodship THJ. Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 1997;8:632-7.
66. Graham KA, Reaich D, Channon SM, et al. Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int 1996;49:1396-400.
67. Stein A, Moorhouse J, Iles-Smith H, et al. Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 1997;52:1089-95.
68. Price SR, Mitch WE. Metabolic acidosis and uremic toxicity: protein and amino acid metabolism. Semin Nephrol 1994;14:232-7.
69. Lowrie EG. Chronic dialysis treatment: clinical outcome and related processes of care. Am J Kidney Dis 1994;24:255-66.
70. Fang C, Tiao G, James H, Ogle C, Fischer JE, Hasselgren P. Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway. J Am Coll Surg 1995;180:161-70.
71. Tiao G, Fagan JM, Samuels N, et al. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J Clin Invest 1994;94:2255-64.
72. Baracos VE, DeVivo C, Hoyle DHR, Goldberg AL. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol 1995;268:E996-1006.